Copyright © 2018 Claristock. All Right Reserved
Total Mark
89
Above 70 is preferred
Stock Analysis
| Growth Potential | 65 | |
|---|---|---|
| Profitability | 100 | |
| Financial Strength | 100 | |
| Result 2019 | 83 | |
| Result 2018 | 82 | |
| Result 2020 | 100 |
Growth Estimate
| 21 Estimate | 22 Estimate | |
|---|---|---|
| Revenue Growth (%) | 12.3 | 10.3 |
| EPS Growth (%) | 6.7 | 12.9 |
| ROE (%) | 31.2 | 26.9 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | ||
|---|---|---|
| Relative Valuation | ||
| Being a Value Stock | ||
| Absolute Valuation |
For more detailed information about Vertex Pharmaceuticals Incorporated, please go to Yahoo Finance